Shenyang Sunshine Pharmaceutical Co., Ltd.

This study tests a new drug called SSGJ-706 combined with standard treatments for people with advanced cancers of the stomach, colon, pancreas, or esophagus that cannot be removed by surgery. About 300 adults aged 18-75 will take part to see if the combination is safe and helps s…

This early-stage trial tests a new drug called SPGL008, alone or with an existing therapy (BCG), in 120 people with high-risk bladder cancer that hasn't invaded muscle. The goal is to find a safe dose and see if it can control the cancer, potentially helping patients avoid bladde…

This early-stage study tests a single dose of a new drug, SSS67, in 52 healthy adults to see if it is safe and how the body processes it. Participants receive either the drug or a placebo by IV, and researchers monitor side effects, drug levels, and immune responses. No treatment…